Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07454499 · ClinicalTrials.gov registry record · NA
Engaging M-health for Symptom Monitoring and Health Promotion for Women on Endocrine Therapy for Breast Cancer (EmSHAPE)
A NA study, sponsored by Abramson Cancer Center at Penn Medicine.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT07454499 is a NA study that is actively recruiting participants, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 60 participants.
The verdict
NCT07454499, a NA study, is actively recruiting participants, sponsored by Abramson Cancer Center at Penn Medicine.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of the study is to learn more about ways to help patients understand and manage side-effects from hormone therapy. The investigators will use the information from this study to design future studies to better understand how our well our tools work to help patients monitor and manage symptoms from hormone therapy and to stay on their hormone therapy for the recommended period of time.
Interventions
- BEHAVIORAL Digital Endocrine therapy Symptom Monitoring and Education Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2026-05-13 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07454499
The ClinicalTrials.gov registry entry for NCT07454499 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Digital Endocrine therapy Symptom Monitoring and Education Intervention is the first listed.
NCT07454499 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07454499 about?
NCT07454499 is a clinical study titled "Engaging M-health for Symptom Monitoring and Health Promotion for Women on Endocrine Therapy for Breast Cancer (EmSHAPE)". The purpose of the study is to learn more about ways to help patients understand and manage side-effects from hormone therapy. The investigators will use the information from this study to design future studies to better understand how our well our tools work to help patients monitor and manage symp...
What is the current status of trial NCT07454499?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2026-05-13. Estimated completion is 2027-12-31.
What interventions are being tested in trial NCT07454499?
The interventions under investigation include: Digital Endocrine therapy Symptom Monitoring and Education Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT07454499?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.